Literature DB >> 17532422

First human transplantation of a nonacceptable donor lung after reconditioning ex vivo.

Stig Steen1, Richard Ingemansson, Leif Eriksson, Leif Pierre, Lars Algotsson, Per Wierup, Qiuming Liao, Atli Eyjolfsson, Ronny Gustafsson, Trygve Sjöberg.   

Abstract

PURPOSE: This article describes an ex vivo method to recondition and transplant rejected donor lungs. DESCRIPTION: A 19-year-old man was brain dead after a traffic accident. A roentgenogram showed bilateral lung contusion. He had ongoing intratracheal bleeding. After optimizing ventilator treatment and suctioning the airways, PaO2 was 9 kPa (67.5 mm Hg) on FiO2 = 0.7. The lungs were rejected by all transplantation centers in the Nordic countries. We harvested the lungs for research. The right lung was severely injured. The left lung was edematous with bleeding spots in the lower lobe, and the mediobasal segment was atelectatic. The left lung was reconditioned ex vivo and kept in topical extracorporeal membrane oxygenation until it was transplanted into a 70-year-old man with chronic obstructive pulmonary disease 17 hours later. EVALUATION: The transplanted lung functioned very well, and the patient recovered uneventfully. At 3 months control, a computed tomographic thoracic scan and transbronchial biopsies showed a normal left lung, and the patient was in very good clinical condition, only to succumb to death from unrelated events 11 months after the transplantation.
CONCLUSIONS: Rejected donor lungs may be successfully transplanted after being reconditioned ex vivo.

Entities:  

Mesh:

Year:  2007        PMID: 17532422     DOI: 10.1016/j.athoracsur.2007.01.033

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  42 in total

1.  Ex vivo lung perfusion as a human platform for preclinical small molecule testing.

Authors:  Nathaniel M Weathington; Diana Álvarez; John Sembrat; Josiah Radder; Nayra Cárdenes; Kentaro Noda; Qiaoke Gong; Hesper Wong; Jay Kolls; Jonathan D'Cunha; Rama K Mallampalli; Bill B Chen; Mauricio Rojas
Journal:  JCI Insight       Date:  2018-10-04

Review 2.  Application of ex vivo lung perfusion (EVLP) in lung transplantation.

Authors:  Xufeng Pan; Jun Yang; Shijie Fu; Heng Zhao
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

3.  Production and assessment of decellularized pig and human lung scaffolds.

Authors:  Joan E Nichols; Jean Niles; Michael Riddle; Gracie Vargas; Tuya Schilagard; Liang Ma; Kert Edward; Saverio La Francesca; Jason Sakamoto; Stephanie Vega; Marie Ogadegbe; Ronald Mlcak; Donald Deyo; Lee Woodson; Christopher McQuitty; Scott Lick; Daniel Beckles; Esther Melo; Joaquin Cortiella
Journal:  Tissue Eng Part A       Date:  2013-06-11       Impact factor: 3.845

Review 4.  Animal models of ex vivo lung perfusion as a platform for transplantation research.

Authors:  Kevin Nelson; Christopher Bobba; Samir Ghadiali; Don Hayes; Sylvester M Black; Bryan A Whitson
Journal:  World J Exp Med       Date:  2014-05-20

5.  Adenosine A₂A agonist improves lung function during ex vivo lung perfusion.

Authors:  Abbas Emaminia; Damien J Lapar; Yunge Zhao; John F Steidle; David A Harris; Victor E Laubach; Joel Linden; Irving L Kron; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2011-10-31       Impact factor: 4.330

6.  Predictors of Older Donor Lung Use: Are We Too Good at Saying No?

Authors:  Ashley Y Choi; Oliver K Jawitz; Vignesh Raman; Samantha E Halpern; John C Haney; Jacob A Klapper; Matthew G Hartwig
Journal:  Ann Thorac Surg       Date:  2020-05-31       Impact factor: 4.330

Review 7.  Normothermic perfusion: a mini-review.

Authors:  Srikanth P Reddy; Jens Brockmann; Peter J Friend
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

8.  Human models of acute lung injury.

Authors:  Alastair G Proudfoot; Danny F McAuley; Mark J D Griffiths; Matthew Hind
Journal:  Dis Model Mech       Date:  2011-03       Impact factor: 5.758

9.  Extracorporeal membrane oxygenation (ECMO) for acute exacerbations of chronic obstructive pulmonary disease: care modalities, experience, and precautions.

Authors:  Yaoji Wang; Pingping Cao
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

10.  A physiologic and biochemical profile of clinically rejected lungs on a normothermic ex vivo lung perfusion platform.

Authors:  Timothy J George; George J Arnaoutakis; Claude A Beaty; Simran K Jandu; Lakshmi Santhanam; Dan E Berkowitz; Ashish S Shah
Journal:  J Surg Res       Date:  2012-11-27       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.